Vaccine Potential of Attenuated Mutants of Corynebacterium pseudotuberculosis in Sheep
- 1 February 1998
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 66 (2), 474-479
- https://doi.org/10.1128/iai.66.2.474-479.1998
Abstract
Corynebacterium pseudotuberculosis, a gram-positive facultative intracellular bacterial pathogen, is the etiological agent of the economically important disease caseous lymphadenitis (CLA) in both sheep and goats. Attenuated mutants of C. pseudotuberculosis have the potential to act as novel vaccines against CLA and as veterinary vaccine vectors. In this report, we have assessed the virulence of both aroQ and pldmutants of C. pseudotuberculosis in sheep and concurrently their capacity to act as vaccines against homologous challenge. The results suggest that aroQ mutants of C. pseudotuberculosis are attenuated with regard to both lymph node persistence and vaccination site reactogenicity. Immunologically,aroQ mutants failed to elicit detectable specific gamma interferon (IFN-γ)-secreting lymphocytes and induced low levels of antibodies to C. pseudotuberculosis culture supernatant antigens. Following subcutaneous vaccination, the immune responses induced by aroQ mutants did not protect sheep from infection with the wild-type strain but did appear to reduce the clinical severity of disease resulting from challenge. Conversely, an attenuated C. pseudotuberculosis strain expressing an enzymatically inactive phospholipase D exotoxin, when used as a vaccine, elicited a protective immune response. Protection appeared to correlate with in vivo persistence of the vaccine strain, the induction of IFN-γ-secreting lymphocytes, and relatively high levels of antibodies to culture supernatant antigens. The results suggest thataroQ mutants of C. pseudotuberculosis may be overly attenuated for use as a CLA vaccines or as vaccine vectors.Keywords
This publication has 35 references indexed in Scilit:
- Lymphocyte subpopulations in pyogranulomas of caseous lymphadenitisClinical and Experimental Immunology, 2008
- Human Lymphadenitis Due to Corynebacterium pseudotuberculosis: Report of Ten Cases from Australia and ReviewClinical Infectious Diseases, 1997
- Phylogenetic Analysis of the Genus Corynebacterium Based on 16S rRNA Gene SequencesInternational Journal of Systematic and Evolutionary Microbiology, 1995
- The spread of Corynebacterium pseudotuberculosis infection to unvaccinated and vaccinated sheepAustralian Veterinary Journal, 1995
- Caseous lymphadenitis vaccine development: site-specific inactivation of the Corynebacterium pseudotuberculosis phospholipase D geneVaccine, 1995
- Targeted mutagenesis of the phospholipase D gene results in decreased virulence ofCorynebacterium pseudotuberculosisMolecular Microbiology, 1994
- Immunity to Intracellular BacteriaAnnual Review of Immunology, 1993
- Immunisation against ovine caseous lymphadenitis: correlation between Corynebacterium pseudotuberculosis toxoid content and protective efficacy in combined clostridial‐corynebacterial vaccinesAustralian Veterinary Journal, 1991
- Immunisation against ovine caseous lymphadenitis: comparison of Corynebacterium pseudotuberculosis vaccines with and without bacterial cellsAustralian Veterinary Journal, 1991
- The effects of caseous lymphadenitis on wool production and bodyweight in young sheepAustralian Veterinary Journal, 1988